Posttransplant Lymphoproliferative Disease after Lung Transplantation

Posttransplant Lymphoproliferative Disease after Lung Transplantation

Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...

Full description

Saved in:

Bibliographic Details
Main Author:	Isabel P. Neuringer
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2013/430209
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01)

Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01)

Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
by: Lokesh K. Jha, et al.
Published: (2018-01-01)

The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention
by: Bryce A. Kiberd, MD, et al.
Published: (2025-05-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
by: Bharat Malhotra, et al.
Published: (2015-01-01)

Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder
by: Pierre Isnard, et al.
Published: (2024-03-01)

Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder
by: Annie Liu, et al.
Published: (2024-09-01)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
by: Sarah E. Halula, et al.
Published: (2015-01-01)

Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature
by: S. Gandhi, et al.
Published: (2020-01-01)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)

Ophthalmoplegia and Tumor Lysis Syndrome: An Uncommon Presentation of Posttransplant Lymphoproliferative Disorder
by: Lauren M. Granat, et al.
Published: (2022-09-01)

Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus–associated Posttransplant Lymphoproliferative Disorder
by: Victor H. Ferreira, PhD, et al.
Published: (2025-04-01)

Posttransplant Lymphoproliferative Disorder Presenting as Testicular Lymphoma in a Kidney Transplant Recipient: A Case Report and Review of the Literature
by: Steve Omoruyi Obanor, et al.
Published: (2018-01-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
by: Clare J. Twist, et al.
Published: (2013-01-01)

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
by: J. Morscio, et al.
Published: (2013-01-01)

Impact of the Composite Allocation Score on Lung Transplant Waitlist and Posttransplant Outcomes
by: Ye In Christopher Kwon, BA, et al.
Published: (2025-07-01)

Yersinia enterocolitica Infection Simulating Lymphoproliferative Disease, after Liver Transplant
by: E. Jakobovich, et al.
Published: (2014-01-01)

Association of Pre–Lung Transplant Opioid Use With Posttransplant Opioid Use and Outcomes
by: Jessica M. Ruck, MD, PhD, et al.
Published: (2025-03-01)

THE INFLUENCE OF POSTTRANSPLANT FACTORS ON THE LONG-TERM SURVIVAL AFTER HEART TRANSPLANTATION
by: V.M. Zakharevich
Published: (2009-05-01)

Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review
by: Matthew G. Cehic, et al.
Published: (2018-01-01)

Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
by: Peihao Zheng, et al.
Published: (2025-02-01)

Primary central nervous system post-transplant lymphoproliferative Disorder in a lung transplant recipient despite reduction of immunosuppression
by: K Afshar, et al.
Published: (2025-02-01)

Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation
by: Xu-Ying Pei, et al.
Published: (2024-11-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Posttransplant Intrarenal Lymphangiectasia
by: Ali Kord, et al.
Published: (2020-01-01)

Lymphoproliferative tumors in rheumatic diseases
by: V. R. Gorodetskiy, et al.
Published: (2024-12-01)

Combination of lymphoproliferative diseases and pregnancy
by: A. L. Chernyshova, et al.
Published: (2023-12-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION IN A ADULT PATIENT: CASE REPORT
by: FZ Piazera, et al.
Published: (2024-10-01)

Optimal Utilization of Donors Aged ≥65 Y in Lung Transplantation to Increase Donor Availability While Maintaining Comparable Posttransplant Outcomes
by: Marniker A. Wijesinha, PhD, et al.
Published: (2025-08-01)

Assessing Risk Factors and Posttransplant Outcomes of Nonadherence Among Kidney Transplant Recipients
by: Kateryna Maksyutynska, HBSc, et al.
Published: (2025-06-01)

WCN24-1548 POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE: A SINGLE CENTER EXPERIENCE
by: Gabriela Gutiérrez, et al.
Published: (2024-04-01)

Posttransplant Erythrocytosis after Allogenic Stem Cell Transplant for Acute Myeloid Leukemia: A Case Report and Review of Literature
by: Sherry S. Abraham, et al.

Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder
by: Heiner Zimmermann, et al.
Published: (2014-01-01)

A response of rituximab plus lenalidomide therapy in patients with post-transplant lymphoproliferative disease and methotrexate-related lymphoproliferative disorder in the central nervous system: a case report
by: Hanguo Guo, et al.
Published: (2025-05-01)

HUMAN HERPESVIRUS 8 AND LYMPHOPROLIFERATIVE DISEASES
by: Maria Luisa Calabrò, et al.
Published: (2018-11-01)

Lymphoproliferative diseases in primary Sjogren's syndrome
by: V. i. Vasiljev, et al.
Published: (2022-11-01)

An Unusual Immediate Posttransplant Eruption
by: Ravi K. Mallavarapu, et al.
Published: (2025-02-01)

The prognostic value of posttransplant chimerism
by: A. A. Sipol, et al.
Published: (2022-11-01)

Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case
by: Sharon Lionel, et al.
Published: (2024-04-01)

HHVs AND LYMPHOPROLIFERATIVE DISORDERS
by: C Quadrelli, et al.
Published: (2011-10-01)